AZD9574
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD9574, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies [Phase 1, Phase 2]